SCHEMBL2900828

SCHEMBL2900828

c1csc(-c2cnc(N3CCN4CCC3CC4)nc2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 4/20 0.37
HTR3A P46098 2/20 0.37
GRIN1 Q05586 1/20 0.37
GRIN2B Q13224 1/20 0.37
CYP3A4 P08684 2/20 0.36
CYP2C9 P11712 2/20 0.36
MAOB P27338 1/20 0.36
CYP2E1 P05181 1/20 0.36
CYP2A6 P11509 1/20 0.36
CYP2B6 P20813 1/20 0.36
CHRNB1 P11230 1/20 0.36
CHRNB2 P17787 1/20 0.36
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36
CHRNB3 Q05901 1/20 0.36
GAK O14976 1/20 0.36
CHRM2 P08172 1/20 0.35
CHRM4 P08173 1/20 0.35
CHRM5 P08912 1/20 0.35
CHRM1 P11229 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2900298 0.99 CHRNA7 (0.39) CHRNA7HTR3AGRIN1GRIN2BCYP3A4
SCHEMBL5358060 0.77 CHRNA7 (0.39) CHRNA7HTR3ACHRM2CHRM4CHRM5
SCHEMBL2899831 0.77 CYP2A6 (0.39) CHRNA7HTR3ACYP2E1CYP2A6CYP2B6
SCHEMBL5358073 0.76 CHRNA7 (0.36) CHRNA7HTR3ACHRM2CHRM4CHRM5
SCHEMBL2895959 0.76 CHRM2 (0.41) CHRNA7HTR3ACHRM2CHRM4CHRM5
SCHEMBL5350554 0.75 CHRNA7 (0.38) CHRNA7HTR3A
SCHEMBL5353379 0.75 KDM4E (0.43) CHRNA7HTR3ACYP2C9ALDH1A1CYP1A2
SCHEMBL5355916 0.75 CHRNA7 (0.38) CHRNA7HTR3AMEN1ALDH1A1LMNA
SCHEMBL6192934 0.75 NPC1 (0.57) CHRNA7HTR3AMAOBMEN1ALDH1A1
SCHEMBL5359078 0.75 HTR3A (0.45) CHRNA7HTR3ACHRNB4CHRNA3CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286128-A1 1,4-DIAZA-BICYCLO[3.2.2]NONYL PYRIMIDINYL DERIVATIVES USEFUL AS NICOTINIC ACETYLCHOLINE-RECEPTOR LIGANDS NEUROSEARCH A/S (DK) 2010-11-11 US claimed
EP-2190846-A1 1,4-DIAZA-BICYCL0(3.2.2)N0NYL PYRIMIDINYL DERIVATIVES USEFUL AS NICOTINIC ACETYLCHOLINE- RECEPTOR LIGANDS NEUROSEARCH A/S (DK) 2010-06-02 EP claimed
WO-2009024515-A1 1,4-DIAZA-BICYCL0(3.2.2)N0NYL PYRIMIDINYL DERIVATIVES USEFUL AS NICOTINIC ACETYLCHOLINE- RECEPTOR LIGANDS NEUROSEARCH A/S (DK) 2009-02-26 WO claimed
US-20100286128-A1 1,4-DIAZA-BICYCLO[3.2.2]NONYL PYRIMIDINYL DERIVATIVES USEFUL AS NICOTINIC ACETYLCHOLINE-RECEPTOR LIGANDS NEUROSEARCH A/S (DK) 2010-11-11 US disclosed
EP-2190846-A1 1,4-DIAZA-BICYCL0(3.2.2)N0NYL PYRIMIDINYL DERIVATIVES USEFUL AS NICOTINIC ACETYLCHOLINE- RECEPTOR LIGANDS NEUROSEARCH A/S (DK) 2010-06-02 EP disclosed
WO-2009024515-A1 1,4-DIAZA-BICYCL0(3.2.2)N0NYL PYRIMIDINYL DERIVATIVES USEFUL AS NICOTINIC ACETYLCHOLINE- RECEPTOR LIGANDS NEUROSEARCH A/S (DK) 2009-02-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286128-A1 1,4-DIAZA-BICYCLO[3.2.2]NONYL PYRIMIDINYL DERIVATIVES USEFUL AS NICOTINIC ACETYLCHOLINE-RECEPTOR LIGANDS CHRNA2, CHRNA5, CHRNA3 CHRNA7 5/4885HTR3A 144/4885GRIN1 262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.